Mounjaro

2023 - 11 - 8

Zepbound Zepbound

Post cover
Image courtesy of "CNN"

FDA approves Eli Lilly's diabetes drug Mounjaro for obesity under ... (CNN)

The US Food and Drug Administration approved the type 2 diabetes drug tirzepatide for use in chronic weight management Wednesday, making official the use of ...

Post cover
Image courtesy of "ABC News"

FDA approves the active ingredient in Mounjaro to help people with ... (ABC News)

The U.S. Food and Drug Administration approved the drug Zepbound for obesity to help people lose weight on Wednesday.

Post cover
Image courtesy of "PBS NewsHour"

FDA approves new version of diabetes drug Mounjaro to be sold for ... (PBS NewsHour)

The drug has been shown to help dieters lose about a quarter of their body weight, or 60 pounds. It is the latest diabetes drug approved for weight loss, ...

Post cover
Image courtesy of "STAT"

Eli Lilly gets FDA approval to sell Mounjaro as obesity drug called ... (STAT)

The obesity approval for tirzepatide introduces stiff competition for Novo Nordisk, which has had shortages of its obesity treatment Wegovy.

Post cover
Image courtesy of "Reuters"

UK's MHRA authorises Lilly's Mounjaro for weight loss (Reuters)

Britain's health regulator on Wednesday authorised Eli Lilly's diabetes drug Mounjaro for weight management and weight loss in the UK, hours after a similar ...

Post cover
Image courtesy of "U.S. News & World Report"

FDA Approves New Version of Diabetes Drug Mounjaro for Weight ... (U.S. News & World Report)

A new version of the popular diabetes treatment Mounjaro can be sold as a weight-loss drug, U.S. regulators announced Wednesday.

Post cover
Image courtesy of "BBC News"

Mounjaro weight loss jab authorised in UK (BBC News)

Trials suggest it can help people shed about 20% of body weight, but it is not recommended for NHS use yet.

Explore the last week